Zoetis (ZTS) has a profit margin of 26.15%, above the Healthcare sector average of 19.13%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
Zoetis (ZTS) currently reports a profit margin of 26.15% as of September 2026. That compares with 28.21% in the prior-year period — down 7.3% year over year. That is above the Healthcare sector average of 19.13%. Use the charts on this page to explore Zoetis's profit margin history and peer comparisons.
Zoetis's profit margin decreased from 28.21% to 26.15% — a 7.3% year-over-year decrease (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Zoetis's profit margin of 26.15% is higher than the Healthcare sector average of 19.13%. That is roughly 36.7% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Zoetis's current 26.15% should be judged against Healthcare norms (sector average: 19.13%) and against ZTS's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of 26.15%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 19.13%. From there, open related valuation or income-statement pages for Zoetis, and consider following ZTS for alerts when major investors trade the stock.